Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
Rebecca H Haberman, Seungha Um, Jordan E Axelrad, Rebecca B Blank, Zakwan Uddin, Sydney Catron, Andrea L Neimann, Mark J Mulligan, Ramin Sedaghat Herat, Simon J Hong, Shannon Chang, Arnold Myrtaj, Ghoncheh Ghiasian, Peter M Izmirly, Amit Saxena, Gary Solomon, Natalie Azar, Jonathan Samuels, Brian D Golden, Paula Rackoff, Samrachana Adhikari, David P Hudesman, Jose U Scher
Topics & Concepts
MedicineImmunogenicityImmunologyVaccinationScopusRheumatologyImmune systemDiseaseAnticardiolipin antibodiesRheum (plant)AdalimumabInfliximabAntibodyMedical journalInflammatory bowel diseaseTumor necrosis factor alphaMEDLINERheumatoid arthritisArthritisInternal medicineAntibody responseMeta-analysisClinical trialSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisImmunotherapy and Immune Responses